Why choose Olink for targeted protein biomarker discovery?

Olink news (Oct 10, 2019)
Olink sponsored Science/AAAS webinar
Now available on-demand! This free webinar describes how advanced proteomics technologies are enabling rapid, noninvasive means for discovering blood-based biomarkers to identify tumor and immune changes associated with immune checkpoint inhibitor response/nonresponse, and to understand primary resistance and toxicity in the field of cancer immunotherapy. Broadcast live on October 9th, 2019, the event is now available as an on-demand recording. The link button below will allow you to watch the recording if you already registered, or to register for the on-demand version if you did not already sign up for the live event.
Publications
Uhlén et al 2019
The human secretome.
Taylor et al 2019
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
Tomalin et al 2019
Early quantification of systemic inflammatory-proteins predicts long-term treatment response to Tofacitinib and Etanercept: Psoriasis response predictions using blood.
Enroth et al 2019
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
News & Events Highlights
Landmark publication on the human sectretome
In a landmark study from Matthias Uhlén’s group at KTH in Stockholm, a novel map...
Molecular Biology Society of Japan 42nd Annual Meeting
Olink is delighted to be both presenting and exhibiting at the 42nd Annual Meeting of t...
New upgrade of Olink's NPX Manager software
In response to feedback from our customers, Olink has just released a signficantly upgr...
Improvements to our Neuro Exploratory panel
In response to customer feedback and as part of Olink’s commitment to improve and...
The Olink Community at the Nobel Forum, Stockholm
View the video and get a flavor of the major international meeting, “Precision Proteomics to Drive Personalized Medicine“, which Olink arranged at the Nobel Forum in Stockholm on June 19, 2018. This global event brought together leading scientists from both academia and industry to listen to a series of outstanding presentations and to engage in important discussions around the increasing importance of protein biomarkers for the development of more personalized healthcare.
Please join our community and get #Olinked by following us on LinkedIn